Skip to main content

2 August 2013

Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.

In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.

Related articles

Aerial Shot Of Forest

John Crane awarded key energy transition contracts in North America

Find out more Call to action arrow icon
Mobile Scanner

Advanced X-ray screening equipment used to help secure NFL Super Bowl

Find out more Call to action arrow icon
Japan Airport

Smiths Detection technology to be used at Fukuoka International Airport 

Find out more Call to action arrow icon